In clinical samples with NSCLC, we found that IL‐6 was an independent predictor of TIM‐4 expression, and patients with TIM‐4 and IL‐6 double high expression showed the worst prognosis. This evidence concerns the gene IL6 and non-small cell lung carcinoma.